A new report found that bots have surpassed human internet traffic. HUMAN Security's State of AI Traffic report found that automated traffic grew eight times faster than human traffic year-over-year.

Bots are taking over the web, according to Cloudflare CEO Matthew Prince. In an interview at the SXSW conference in Austin this week, he said that with the speed at which artificial intelligence is ...

MP_DECLARE_CONST_FUN_OBJ_VAR_BETWEEN(mod_os_errno_obj); MP_DECLARE_CONST_FUN_OBJ_1(mod_os_getenv_obj); MP_DECLARE_CONST_FUN_OBJ_1(mod_os_system_obj); STATIC const mp ...

Meta, the company behind some of the world’s most popular social media platforms, just scooped up a new site – for bots. Meta has acquired Moltbook, the social media network where AI agents interact ...

An open source project called Scrapling is gaining traction with AI agent users who want their bots to scrape sites without permission. “No bot detection. No selector maintenance. No Cloudflare ...

Feb 15 (Reuters) - Peter Steinberger, the founder of OpenClaw, is joining OpenAI, and the open-source bot is becoming a foundation, OpenAI CEO Sam Altman said on Sunday. "Peter Steinberger is joining ...

From small publishers to US federal agencies, websites are reporting unusual spikes in automated traffic linked to IP addresses in Lanzhou, China. When he first noticed the traffic spike, Quintero ...

Forbes contributors publish independent expert analyses and insights. Kate O’Flaherty is a cybersecurity and privacy journalist. This voice experience is generated by AI. Learn more. This voice ...

Can computer programs have faith? Can they conspire against the humans that created them? Or feel melancholy? On a social media platform built just for artificial intelligence bots, some of them are ...

Humans have left the chat. AI bots now have their very own social network — and they’re ready to delete humanity. A revolutionary new social media platform called Moltbook debuted this week, giving AI ...

FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...